Mycobacterium chimaera colonisation of heater–cooler units (HCU) in Western Australia, 2015: investigation of possible iatrogenic infection using whole genome sequencing by Robinson, J. et al.
www.eurosurveillance.org
Vol. 21  |  Weekly issue 46  |  17 November 2016
E u r o p e ’ s  j o u r n a l  o n  i n f e c t i o u s  d i s e a s e  e p i d e m i o l o g y,  p r e v e n t i o n  a n d  c o n t r o l
Editorials
Mycobacterium chimaera infections associated with heater-cooler units (HCU): closing 
another loophole in patient safety 2
by MJ Struelens, D Plachouras
Rapid communications
Outbreak of enterovirus D68 of the new B3 lineage in Stockholm, Sweden, August to 
September 2016 5
by R Dyrdak, M Grabbe, B Hammas, J Ekwall, KE Hansson, J Luthander, P Naucler, H Reinius, M Rotzén-
Östlund, J Albert
Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016 11
by D Antona, M Kossorotoff, I Schuffenecker, A Mirand, M Leruez-Ville, C Bassi, M Aubart, F Moulin, D 
Lévy-Bruhl, C Henquell, B Lina, I Desguerre
Surveillance report
Mycobacterium chimaera colonisation of heater–cooler units (HCU) in Western 
Australia, 2015: investigation of possible iatrogenic infection using whole genome 
sequencing  15
by JO Robinson, GW Coombs, DJ Speers, T Keehner, AD Keil, V D’Abrera, P Boan, S Pang
Research Articles
Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices 
used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016 19
by FC Trudzinski, U Schlotthauer, A Kamp, K Hennemann, RM Muellenbach, U Reischl, B Gärtner, H 
Wilkens, R Bals, M Herrmann, PM Lepper, SL Becker
Review articles
Prevention of hospital-acquired bloodstream infections through chlorhexidine 
gluconate-impregnated washcloth bathing in intensive care units: a systematic review 
and meta-analysis of randomised crossover trials 27
by E Afonso, K Blot, S Blot
News
Eurosurveillance 5th scientific seminar on 30 November at ESCAIDE - 20 years of 
communicating facts and figures in a changing world 38
by Eurosurveillance editorial team
ECDC publishes 2015 surveillance data on antimicrobial resistance and antimicrobial 
consumption in Europe 39
by K Weist, LD Högberg
15www.eurosurveillance.org
Surveillance and outbreak report 
Mycobacterium chimaera colonisation of heater–cooler 
units (HCU) in Western Australia, 2015: investigation 
of possible iatrogenic infection using whole genome 
sequencing
JO Robinson 1 2 3 4 , GW Coombs 3 4 , DJ Speers 5 6 , T Keehner ⁵ , AD Keil ⁵ , V D’Abrera ⁷ , P Boan 2 3 , S Pang 3 4 
1. Royal Perth Hospital, Perth, Australia
2. Fiona Stanley Hospital, Perth Australia
3. Pathwest Laboratory Medicine WA, Fiona Stanley Hospital Network, Perth, Australia
4. Australian Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS) Typing and Research, School of 
Veterinary and Life Sciences, Murdoch University and School of Biomedical Sciences, Curtin University, Perth, Australia
5. PathWest Laboratory Medicine WA, Hospital Avenue, Nedlands, Australia
6. School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia
7. St John of God Pathology, Perth, Australia
Correspondence: James Owen Robinson (owen.robinson@health.wa.gov.au)
Citation style for this article: 
Robinson JO, Coombs GW, Speers DJ, Keehner T, Keil AD, D’Abrera V, Boan P, Pang S. Mycobacterium chimaera colonisation of heater–cooler units (HCU) in 
Western Australia, 2015: investigation of possible iatrogenic infection using whole genome sequencing. Euro Surveill. 2016;21(46):pii=30396. DOI: http://dx.doi.
org/10.2807/1560-7917.ES.2016.21.46.30396 
Article submitted on 06 September 2016 / accepted on 04 October 2016 / published on 17 November 2016
Following the reported link between heater–cooler 
unit (HCU) colonisation with Mycobacterium chimaera 
and endocarditis, mycobacterial sampling of all HCUs 
in use in Western Australia was initiated from August 
2015, revealing M. chimaera colonisation in 10 of 15 
HCUs. After M. chimaera was isolated from a pleural 
biopsy from a cardiothoracic patient who may have 
been exposed to a colonised HCU, a whole genome 
sequencing investigation was performed involving 
65 specimens from 15 HCUs across five hospitals to 
assess if this infection was related to the HCU. Genetic 
relatedness was found between the 10 HCU M. chi-
maera isolates from four hospitals. However the M. 
chimaera isolate from the cardiothoracic patient was 
not genetically related to the HCU M. chimaera iso-
lates from that hospital, nor to the other HCU isolates, 
indicating that the HCUs were not the source of the 
infection in this patient.
Introduction
Mycobacterium chimaera is a slow growing mycobacte-
rium from the Mycobacterium avium complex. In 2004, 
M. chimaera was identified as a new species within 
the complex group [1] and has been associated with 
pulmonary infections, predominantly in immunosup-
pressed patients and in patients with pre-existing lung 
conditions such as chronic obstructive pulmonary dis-
ease and cystic fibrosis [2,3]. Since 2013, M. chimaera 
has been reported as a cause of prosthetic valve endo-
carditis, bloodstream and vascular graft infections in 
several countries in Europe and the United States (US) 
[4-10], linked to the colonisation of the heater–cooler 
units (HCUs) used during open heart surgery with pos-
tulated airborne transmission in the operating theatre 
[8,11].
In June 2015, an HCU manufacturer issued a warning, 
instructing hospitals to follow updated disinfection 
and maintenance procedures on HCUs and perform 
mycobacterial sampling. In response, private and pub-
lic hospitals in Western Australia (WA) commenced 
mycobacterial sampling of their HCUs (all HCUs in WA 
have been purchased from the same manufacturer) 
in August 2015. In March 2016, a clinical isolate of M. 
chimaera was obtained from a cardiothoracic surgical 
patient in whom the surgery involved the use of one 
of the HCUs. This finding triggered an investigation to 
assess if this infection was related to the HCU.
Case report and environmental sampling
A patient in their 50s underwent cardiothoracic sur-
gery employing a HCU for cardiopulmonary bypass 
at Hospital 4 in December 2015. The surgery did not 
involve the implantation of prosthetic material. During 
this surgery, the HCU was placed as far as possible 
from the patient, with the exhaust towards the theatre 
exhaust vent and away from the patient.
Following the warning from the manufacturer, the 
water of all five HCUs at Hospital 4 was cultured and 
four of the five HCUs tested positive for M. chimaera in 
October 2015. All HCUs therefore underwent cleaning 
and disinfection following the manufacturer’s instruc-
tion and were then deemed safe for use, the risk of 
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postponing surgery while waiting for culture results 
being greater than the potential residual infective risk. 
As part of the monthly testing protocol, the HCUs were 
again sampled in November 2015 and M. chimaera was 
again cultured from one of the five HCUs after a 53-day 
incubation, i.e. after the patient’s surgery. As the spe-
cific HCU used at the time of surgery was not recorded, 
it was not possible to conclude or exclude that the 
patient was exposed to a HCU colonised with M. chi-
maera. A process of recording the HCU used for each 
patient surgery has since been introduced.
Air sampling was also attempted from the operat-
ing theatres at Hospital 4, but the sampling plates 
were overgrown with other organisms such that inter-
pretation of mycobacterial growth was not possible. 
Sampling from other hospital sources, such as potable 
water was not attempted.
One month after the operation, the patient devel-
oped bilateral pleural effusions and a pneumotho-
rax with Pseudomonas aeruginosa isolated from the 
pleural fluid. During a 6-week course of piperacillin/
tazobactam, the patient required four pleural drain-
age procedures, three for recurrent effusion and one 
for pneumothorax. One week after cessation of antibi-
otics, the patient redeveloped a pleural effusion and 
P. aeruginosa was again cultured. At this point the 
patient underwent decortication, and M. chimaera was 
cultured from a pleural biopsy. The patient was com-
menced on a combination of piperacillin/tazobactam, 
ciprofloxacin, azithromycin and ethambutol and slowly 
improved. Of note, the patient did not have signs and 
symptoms of disseminated M. chimaera infection. 
Mycobacterial blood cultures were not performed.
Methods
Mycobacterial culture from HCUs was performed at the 
Western Australian mycobacterial reference labora-
tory. Mycobacteriology culture methods for water sam-
ples based on the 2010 Gastroenterological Society of 
Australia guidelines [12] and comparable with subse-
quent British [13] and European [14] guidelines for M. 
chimaera isolation were followed. Aliquots of 50 mL 
were centrifuged at 3,000 g for 20 min, the superna-
tant discarded and the remaining 1–2 mL decontami-
nated using n-acetyl-l-cysteine-sodium hydroxide/
sodium citrate. Two BBL MGIT tubes (Mycobacteria 
Growth Indicator Tube, Becton Dickinson, Sparks, US) 
and two Gerloff’s egg slopes (with added nalidixic 
acid, vancomycin, amphotericin and polymyxin) were 
each inoculated with 0.5 mL of the processed sample 
and incubated for 8 weeks at 30 °C and 36 °C. Positive 
cultures were confirmed by acid fast staining, with 
subculturing on Middlebrook 7H11 plates for purity and 
identification. Single colony identification was per-
formed by 16S rRNA gene sequencing.
The pleural biopsy was similarly cultured but without 
NaOH processing, with the clinical isolate initially iden-
tified on solid media at 30 °C after 21 days.
Whole genome sequencing (WGS), using aMiSeq plat-
form (Illumina, San Diego, US), was performed on all 
HCU M. chimaera isolates, the patient isolate and a 
M. chimaera isolate from a non-cardiothoracic patient. 
M. chimaera strain MCIMRL6 (NCBI accession number: 
LJHN01000001), a clinical respiratory isolate, was used 
as the reference sequence [15]. The Illumina paired-
end sequencing data, with an average of 70 × coverage 
depth, were analysed for genetic relatedness using the 
Nullarbor bioinformatic pipeline software [16] to iden-
tify single nucleotide polymorphisms (SNPs) in the core 
genome by comparison with the reference sequence. 
SNPs in recombination events were removed based on 
the method described by Feng et al. A maximum parsi-
mony phylogenetic tree was constructed using MEGA 
(v7.0) [17].
Results
Sixty-five specimens from 15 HCUs used in five WA hos-
pitals were cultured for mycobacteria over a 12-month 
period from August 2015 to July 2016. The sampling 
pattern initially varied between hospitals but became 
more regular for all hospitals with HCUs over time as 
standardised testing intervals were established. Single 
mycobacterial isolates from 10 different HCUs from four 
hospitals, as well as the patient isolate and the sec-
ond clinical isolate from a non-cardiothoracic patient 
were confirmed as M. chimaera by WGS. In addition, M. 
intracellulare and M. gordonae were also isolated from 
HCUs. The M. chimaera HCU isolates clustered into two 
groups, one from Hospital 4 and one from Hospitals 
Figure 
Genomic analysis of Mycobacterium chimaera strains 
grown from heater–cooler units from four hospitals, 
the cardiothoracic patient from Hospital 4 and a non-




































Patient 1: Hospital 4 cardiothoracic patient isolate, December 
2015; patient 2: non-cardiothoracic patient isolate; reference: 
M chimaera strain MCIMRL6 (NCBI accession number: 
LJHN01000001).
Numbers indicate single nucleotide polymorphism differences.
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1–3. The two groups differed by 28 SNPs, with 2–17 
SNP differences between isolates within a group. The 
isolate from the patient in Hospital 4 did not cluster 
with the Hospital 4 HCU isolates; it differed from them 
by at least 63 SNPs (Figure). Likewise, the non-cardi-
othoracic patient isolate did not cluster with the HCU 
isolates.
Discussion
An association of HCU colonisation with M. chimaera 
and subsequent deep tissue infections in cardio-pul-
monary bypass patients has been reported in Europe 
and the US [5-7,11] but published molecular epidemio-
logical information is scarce [8]. Our WGS investigation 
revealed frequent M. chimaera colonisation of HCUs 
across several hospitals in WA. The WGS results show 
that the HCU M. chimaera isolates in WA were geneti-
cally related as they all shared common SNPs, which is 
consistent with contamination from a common source. 
There was no transfer of HCUs between hospitals in 
WA to implicate a single hospital contamination event. 
The hospital tap water supply cannot be excluded as 
a source, but only sterile packaged water or filtered 
tap water is used in the filling and cleaning of HCUs 
in WA. Given that all the HCUs in WA were produced 
at the same manufacturing site, one hypothesis is the 
HCUs were contaminated during production at this site, 
as recently suggested by Haller et al. [6]. In their study 
they showed that isolates from cardiothoracic patients, 
HCUs and the manufacturing site were almost identical; 
however, their typing results have not been published. 
To examine this hypothesis further, systematic WGS 
of isolates collected from HCUs in multiple geographi-
cal locations is required. Notably, the two HCUs from 
the WA hospital that did not yield any positive cultures 
for M. chimaera were significantly older (more than 10 
years) than the HCUs in Hospitals 1–4 and thus may 
have been manufactured before a possible contamina-
tion event at the manufacturing site.
The M. chimaera isolate from the cardiothoracic patient 
was not genetically related to the HCU M. chimaera iso-
lates from that hospital, nor to the other HCU isolates, 
indicating that the HCUs were not the source of the 
infection in this patient. Although this finding is reas-
suring, the presence of multiple different strains in an 
individual specimen may not have been detected by 
our sampling method as only one colony was selected 
from the culture media for WGS. Furthermore, M. chi-
maera cases have been diagnosed up to five years 
after cardiovascular surgery [6] and therefore we may 
detect linked clinical cases into the future.
Interestingly, both patient isolates and the reference 
strain were from respiratory specimens but were not 
closely related to each other or to the HCU isolates. 
This would suggest heterogeneity in the environmen-
tal M. chimaera populations able to infect the respira-
tory tract of these patients and the HCUs. Due to the 
probability of contamination with M. chimaera at the 
overseas manufacturing site it is possible that the 
observed genetic differences between the patient and 
HCU isolates may simply reflect different M. chimaera 
populations in water sources in the two countries. It is 
currently unknown if different M. chimaera strains have 
different pathogenicity to cause infections of either 
prosthetic heart valves or the respiratory tract.
Conclusion
Our study has demonstrated the usefulness of WGS 
in the analysis of a potential iatrogenic M. chimaera 
infection and shown that some HCUs used in WA are 
colonised with M. chimaera, as observed in countries 
on the northern hemisphere. As yet, no HCU-related 
infections have been identified in patients undergoing 
cardiopulmonary bypass procedures in WA. We must 
maintain a high level of suspicion in the population at 
risk while continuing regular disinfection and mycobac-
terial monitoring of our HCUs.
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